LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
3.450
-0.010 (-0.29%)
At close: Aug 14, 2026, 4:00 PM EDT
3.734
+0.284 (8.22%)
After-hours: Aug 14, 2026, 7:51 PM EDT
LifeMD Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 191.59 | 194.06 | 154.82 | 152.55 | 119.03 | 92.88 | |
Revenue Growth | 20.75% | 25.34% | 1.49% | 28.16% | 28.16% | 149.04% |
Cost of Revenue | 23.95 | 27.71 | 21.44 | 18.9 | 18.67 | 18 |
Gross Profit | 167.64 | 166.34 | 133.38 | 133.65 | 100.37 | 74.88 |
Selling, General & Admin | 170.05 | 157.09 | 139.37 | 136.64 | 131.23 | 124.96 |
Research & Development | 7.25 | 7.35 | 6.86 | 6.06 | 2.97 | 0.95 |
Other Operating Expenses | 10.54 | 9.57 | 7.56 | 5.44 | 5.85 | 3.27 |
Operating Expenses | 187.84 | 174.01 | 153.79 | 148.14 | 140.05 | 129.18 |
Operating Income | -20.2 | -7.67 | -20.4 | -14.49 | -39.69 | -54.3 |
Interest Expense | -0.24 | -1.36 | -2.18 | -2.6 | -1.28 | -3.02 |
EBT Excluding Unusual Items | -20.33 | -9.03 | -22.58 | -17.09 | -40.96 | -57.32 |
Impairment of Goodwill | - | - | - | - | -8 | - |
Asset Writedown | - | - | - | - | -0.86 | - |
Other Unusual Items | -1.16 | -1.16 | - | -0.33 | 5.16 | -4 |
Pretax Income | -21.49 | -10.19 | -22.58 | -17.41 | -44.66 | -61.32 |
Income Tax Expense | 0.05 | 0.05 | 0.6 | 0.43 | 0.36 | 0.01 |
Earnings From Continuing Operations | -21.54 | -10.23 | -23.18 | -17.84 | -45.02 | -61.32 |
Earnings From Discontinued Operations | 21.97 | 25.85 | 2.32 | - | - | - |
Net Income to Company | 0.43 | 15.62 | -20.86 | -17.84 | -45.02 | -61.32 |
Minority Interest in Earnings | -0.23 | -1.27 | -0.55 | -2.76 | -0.51 | 0.43 |
Net Income | 0.2 | 14.35 | -21.41 | -20.6 | -45.54 | -60.9 |
Preferred Dividends & Other Adjustments | 3.11 | 3.11 | 3.11 | 3.11 | 3.11 | 0.87 |
Net Income to Common | -2.91 | 11.25 | -24.52 | -23.7 | -48.64 | -61.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 47 | 45 | 41 | 34 | 31 | 27 |
Shares Outstanding (Diluted) | 47 | 45 | 41 | 34 | 31 | 27 |
Shares Change | 9.50% | 9.55% | 21.50% | 9.46% | 14.69% | 89.20% |
EPS (Basic) | -0.06 | 0.25 | -0.60 | -0.70 | -1.57 | -2.29 |
EPS (Diluted) | -0.09 | 0.25 | -0.60 | -0.70 | -1.57 | -2.29 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -7.84 | 6.41 | 13.7 | 8.62 | -23.3 | -33.33 |
Free Cash Flow Per Share | -0.17 | 0.14 | 0.33 | 0.25 | -0.75 | -1.23 |
Gross Margin | 87.50% | 85.72% | 86.15% | 87.61% | 84.32% | 80.62% |
Operating Margin | -10.54% | -3.95% | -13.18% | -9.50% | -33.34% | -58.47% |
Profit Margin | -1.52% | 5.80% | -15.83% | -15.54% | -40.86% | -66.51% |
Free Cash Flow Margin | -4.09% | 3.30% | 8.85% | 5.65% | -19.58% | -35.89% |
EBITDA | -18.96 | -6.71 | -19.91 | -13.31 | -38.6 | -53.95 |
EBITDA Margin | -9.89% | -3.46% | -12.86% | -8.73% | -32.43% | -58.08% |
D&A For EBITDA | 1.24 | 0.96 | 0.49 | 1.18 | 1.09 | 0.36 |
EBIT | -20.2 | -7.67 | -20.4 | -14.49 | -39.69 | -54.3 |
EBIT Margin | -10.54% | -3.95% | -13.18% | -9.50% | -33.34% | -58.47% |
Revenue as Reported | - | - | - | 152.55 | 119.03 | 92.88 |